The purpose of this study is to evaluate the effect of Prostaglandin I2 analogue use on the
development of chronic allograft nephropathy and changes in allograft function in prevalent
renal transplant recipients
Drug: prostaglandin I2 analogue
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01056835
Ages eligible for Study
20 Years to 50 Years
Genders eligible for Study
Accepts Healthy Volunteers
prevalent renal transplant recipients 2 years after transplantation
no history of acute rejection
stable renal function
history of biopsy-proven chronic allograft nephropathy
history of biopsy-proven CNI nephrotoxicity
history of biopsy-proven or clinical acute rejection
unstable trough level of CNI or extremely low level of CNI
Tris trial is registered with FDA with number: NCT01056835. The sponsor of the trial is Seoul National University Hospital and it is looking for 40 volunteers for the current phase.
Official trial title: Effects of PGI2 Analogue Use on the Development of Chronic Allograft Nephropathy
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
Consult your doctor?
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.